Imperial College Healthcare NHS Trust provides acute and specialist healthcare for over one million people every year.
We are Imperial College Healthcare
![Portrait of nurse sharing a laugh with colleagues while on her shift Portrait of nurse sharing a laugh with colleagues while on her shift](/-/media/website/images/landing-page-images/whoweare-954x556.png?rev=6e7a194ac37343c6b0b5bc90f22aa496&as=1&h=556&w=954&la=en&hash=8F7B33E66B6C3F9CA78E6F286E574B19)
We particularly serve the local communities in the eight boroughs that form the North West London Integrated Care System. Formed in 2007, we are one of the largest NHS trusts in the country, with more than 15,000 staff.
Our five hospitals in central and west London – Charing Cross, Hammersmith, Queen Charlotte’s & Chelsea, St Mary’s and The Western Eye – have a long track record in research and education, influencing care and treatment nationally and worldwide. We are developing a growing range of integrated and digital care services and offer private healthcare in dedicated facilities on all our sites, including at the Lindo Wing at St Mary’s Hospital.
![St Mary’s Hospital](/-/media/website/locations/st-marys-hospital/st-marys-hospital.jpg?rev=9622e5e3c60c43529df9aadc914f6f72&as=1&h=556&w=954&la=en&hash=5611AC313FA7A9226E3627811A595147)
Building better hospitals
All three of the Trust’s main sites are included in the Government’s New Hospital Programme. This includes a full rebuild of St Mary’s and major refurbishment and some new build at both Charing Cross and Hammersmith hospitals. A new Western Eye Hospital is expected to be incorporated into whichever is the most suitable of the developments.
Latest news See all news
-
Read the full story
Statement on next steps for the redevelopment of St Mary’s Hospital
The New Hospital Programme has confirmed that the Trust will be able to continue to detailed design and planning for its St Mary’s Hospital redevelopment in Paddington.
-
Read the full story
COVID-19 linked to increase in biomarkers for abnormal brain proteins
Researchers have uncovered a link between COVID-19 and blood markers linked to faulty proteins in the brain.
-
Read the full story
Personalising risk from COVID-19 key to protecting immunosuppressed people
New research underscores the need for ongoing COVID-19 protection for people with weakened immune systems.